GlobeNewswire 12/10/2018 Changes to the Roche Corporate Executive Committee
GlobeNewswire 12/7/2018 FDA approves Roche's Tecentriq in combination with Avastin and chemotherapy for the initial treatmen...
GlobeNewswire 12/5/2018 Roche's Kadcyla cut the risk of disease recurring by half compared to Herceptin in people with HER2-...
GlobeNewswire 12/5/2018 FDA grants priority review to Roche's Tecentriq in combination with chemotherapy for the initial tre...
GlobeNewswire 12/4/2018 New Venclexta/Venclyxto data demonstrate deep responses in two of the most common types of leukaemia
GlobeNewswire 12/3/2018 Roche's Hemlibra provided sustained bleed control in the largest pivotal study to date of children w...
GlobeNewswire 12/3/2018 Longer-term follow-up data demonstrate sustained benefit of polatuzumab vedotin-based treatment in r...
GlobeNewswire 11/26/2018 Global Spinal Muscular Atrophy Market Forecast 2017-2026: Increasing Funding for Research & Developm...
GlobeNewswire 11/21/2018 Roche announces FDA grants Venclexta accelerated approval for people with newly-diagnosed acute myel...
TeleTrader 11/20/2018 Fitch cuts Novartis to AA- for 'acquisitive strategy'
GlobeNewswire 11/13/2018 FDA grants priority review to Roche's Tecentriq in combination with Abraxane for the initial treatme...
GlobeNewswire 11/6/2018 Global Laboratory Automation Market to 2023: The $4.3 Billion Market is 2017 is Expected to Reach $5...
GlobeNewswire 11/1/2018 Roche to present new data from its industry-leading haematology portfolio at the American Society of...
GlobeNewswire 11/1/2018 Phase III data showed that Venclexta/Venclyxto plus Gazyva/Gazyvaro reduced the risk of disease wors...
GlobeNewswire 11/1/2018 Roche announces EU approval of Venclyxto plus MabThera for people with previously treated chronic ly...
GlobeNewswire 10/29/2018 New STAIRWAY study data shows potential for extended durability with Roche's faricimab in neovascula...
GlobeNewswire 10/24/2018 Roche announces FDA approval of Xofluza (baloxavir marboxil) for influenza
GlobeNewswire 10/22/2018 Roche's Alecensa (alectinib) significantly reduced the risk of disease worsening or death as first-l...
GlobeNewswire 10/22/2018 Roche's Tecentriq plus chemotherapy (carboplatin and Abraxane) as an initial treatment helped people...
GlobeNewswire 10/21/2018 Roche's investigational personalised medicine entrectinib shrank tumours in people with NTRK fusion-...
GlobeNewswire 10/20/2018 Roche's Tecentriq in combination with Abraxane improves outcomes as an initial treatment for people ...
GlobeNewswire 10/18/2018 Global Digital Transformation Markets 2018-2023: Detailed Forecasts by Application and Service, Use ...
GlobeNewswire 10/17/2018 Roche reports very strong growth in the first nine months of 2018
GlobeNewswire 10/15/2018 Global Personalized Medicine Market to 2024: Personalized Cancer Therapy Gets a Boost from Patient-D...
GlobeNewswire 10/15/2018 Roche launches NGS AVENIO Tumor Tissue Analysis Kits for oncology research